Ping Wang, Ph.D., MBA, Janssen - Qepler Summits And Conferences

Ping Wang, Ph.D., MBA

Scientific Director
Malvern, Pennsylvania, USA
Pharmaceutical Companies of Johnson & Johnson | Janssen

Dr. Ping Wang is a Scientific Director with Janssen R&D.

He has been leading Janssen’s effort in the evaluation, selection and risk assessment related to polymeric materials used in the manufacturing, packaging and delivery of biologics, small molecules and transdermal drug products for the past decade.

His main interests and expertise are risk-based material evaluation, E&L strategies and methodologies, single use systems, biocompatibility, biologics drug development, analytical technologies, regulatory implications and toxicological assessment of impurities.

He is a board member of Extractables and Leachables Safety Information Exchange (ELSIE) Consortium. As an active member of Biophorum Operations Group (BPOG), he was a key contributor to the BPOG’s standardized extractable protocol, and the best practice guide for leachable risk assessment.

He is a holder of Regulatory Affairs Certificate (RAC).

Related Sessions:

2nd Annual Extractables &
Leachables Summit 2020

Get the latest updates in regulation, analytical testing, risk & safety assessment, biocompatibility.
  • 22 Oct 2020
  • Virtual,
  • Pharma
Day 2: Friday, 23 October 2020
CASE STUDY: BioPhorum (BPOG) Extractable Recommendations for SUS – Final Chapter, and an end user’s data mining experience

Will discuss the new BPOG protocol ver 2.0, and own experience with various extractable data sets, acquired over the years.

View Details